THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES. (June 2017)

Record Type:
Journal Article
Title:
THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES. (June 2017)
Main Title:
THE DUAL SYK/JAK INHIBITOR CERDULATINIB DEMONSTRATES RAPID TUMOR RESPONSES IN a PHASE 2 STUDY IN PATIENTS WITH RELAPSED/REFRACTORY B‐CELL MALIGNANCIES
Authors:
Hamlin, P.A.
Farber, C.M.
Fenske, T.S.
Khatcheressian, J.L.
Miller, C.B.
Munoz, J.
Patel, M.R.
Schreeder, M.T.
Smith, S.M.
Stevens, D.A.
Pandey, A.
Birrell, M.R.
Leeds, J.M.
Wang, Y.L.
Coffey, G.P.
Curnutte, J.T.
Abstract:
Is Part Of:
Hematological oncology. Volume 35(2017)Supplement 2
Journal:
Hematological oncology
Issue:
Volume 35(2017)Supplement 2
Issue Display:
Volume 35, Issue 2 (2017)
Year:
2017
Volume:
35
Issue:
2
Issue Sort Value:
2017-0035-0002-0000
Page Start:
74
Page End:
74
Publication Date:
2017-06
Subjects:
Hematological oncology -- Periodicals
Hematology
Medical Oncology
616.99418005
Journal URLs:
http://onlinelibrary.wiley.com/ ↗
DOI:
10.1002/hon.2437_61 ↗
Languages:
English
ISSNs:
0278-0232
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - 4291.550000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:
2815.xml